Olema Oncology to Present at Cowen 42nd Annual Health Care Conference
SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), announced today that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer,
